ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
ViiV Healthcare presented Phase IIIb VOGUE trial data comparing two-drug Dovato to three-drug Biktarvy in treatment-naïve adults with HIV at AIDS 2026.
Read MoreThe CDC is investigating nearly 7,000 suspected cyclosporiasis cases across 34 states since May 2026, with 1,645 confirmed infections.
Read MoreThe FDA approved Leqembi Iqlik subcutaneous injections as a once-weekly starting dose for early Alzheimer’s disease treatment at home.
Read MoreMichigan reports over 3,000 cyclosporiasis cases linked to lettuce and salad greens in southeast counties as of July 13, 2026.
Read MoreLupin Pharmaceuticals recalled over 2.5 million bottles of Prednisolone Acetate eye drops in the U.S. due to potential contamination concerns.
Read MoreThe FDA recalled over 2 million bottles of OTC eye drops nationwide due to potential contamination risking eye infections and vision loss.
Read MoreWyoming reports third 2026 measles case in an unvaccinated adult in Teton County, underscoring the disease’s contagious risk.
Read MoreThe FDA approved Sarclisa Escena, an on-body injector delivering isatuximab for multiple myeloma treatment, marking a first in anticancer therapy delivery.
Read MoreHealthcare ransomware attacks surged in H1 2026 as extortion groups expanded tactics to include supply chain attacks, targeting the sector heavily.
Read MoreIKS Health will acquire TruBridge for $557 million in cash, including $427 million equity and $130 million debt, with earnings accretion expected by 2027.
Read More